Sumatriptan Succinate 100 mg Tablets Under Non-Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

August 31, 2004

Primary Completion Date

September 30, 2004

Study Completion Date

October 31, 2004

Conditions
Healthy
Interventions
DRUG

Sumatriptan Succinate

100 mg Tablet

DRUG

Imitrex®

100 mg Tablet

Trial Locations (1)

63301

Gateway Medical Research, Inc., Saint Charles

All Listed Sponsors
lead

Teva Pharmaceuticals USA

INDUSTRY

NCT00846885 - Sumatriptan Succinate 100 mg Tablets Under Non-Fasting Conditions | Biotech Hunter | Biotech Hunter